HighMark Wealth Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-840
| Closed | -$1.26K | – | 630 |
|
|
2023
Q1 | $1.26K | Hold |
840
| – | – | ﹤0.01% | 528 |
|
|
2022
Q4 | $839 | Hold |
840
| – | – | ﹤0.01% | 484 |
|
|
2022
Q3 | $2K | Hold |
840
| – | – | ﹤0.01% | 453 |
|
|
2022
Q2 | $2K | Hold |
840
| – | – | ﹤0.01% | 454 |
|
|
2022
Q1 | $2K | Hold |
840
| – | – | ﹤0.01% | 465 |
|
|
2021
Q4 | $4K | Sell |
840
-495
| -37% | -$2.36K | ﹤0.01% | 391 |
|
|
2021
Q3 | $11K | Buy |
1,335
+295
| +28% | +$2.43K | 0.01% | 244 |
|
|
2021
Q2 | $17K | Sell |
1,040
-65
| -6% | -$1.06K | 0.01% | 203 |
|
|
2021
Q1 | $24K | Buy |
+1,105
| New | +$24K | 0.02% | 158 |
|